title: The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices.
authors.affiliation: Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland. Electronic address: matthew.hillebrenner@fda.hhs.gov.
authors.forename: Matthew
authors.initials: M
authors.lastname: Hillebrenner
authors.affiliation: Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Bram
authors.initials: B
authors.lastname: Zuckerman
authors.affiliation: Office of the Commissioner, U.S. Food and Drug Administration, Silver, Spring, Maryland.
authors.forename: Mona
authors.initials: M
authors.lastname: Fiuzat
authors.affiliation: Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver, Spring, Maryland.
authors.forename: Norman
authors.initials: N
authors.lastname: Stockbridge
authors.affiliation: Office of the Commissioner, U.S. Food and Drug Administration, Silver, Spring, Maryland.
authors.forename: Robert
authors.initials: R
authors.lastname: Califf
mesh_terms: D004868:Equipment Failure; D006333:Heart Failure / Q000628:therapy; D049674:History, 21st Century; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration / Q000639:trends*
keywords: heart failure; regulation